Back
Bio-Rad Laboratories Vs. Neurogene Industry Stock Comparison
Buy
54
BIO
Bio-Rad Laboratories
Last Price:
354.04
Seasonality Move:
7.32%
Sell
5
NGNE
Neurogene
Last Price:
39.91
Seasonality Move:
50.43%
Buy
54
Bio-Rad Laboratories (BIO)
is a Buy
Is Bio-Rad Laboratories a Buy, Sell or Hold?
- The current Bio-Rad Laboratories [BIO] share price is $363.20. The Score for BIO is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- BIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
5
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BIO Stock Price Chart
What is Bio-Rad Laboratories's stock price today?
-
The Bio-Rad Laboratories share price today is $363.20
The current trend is moderately bullish and BIO is experiencing slight buying pressure.
BIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.06 | Buy |
| Relative Strength Index (14 RSI): | 59.43 | Buy |
| Chaikin Money Flow: | 32861 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (330.98 - 365.34) | Buy |
| Bollinger Bands (100): | (299.96 - 349.24) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.3 | Buy |
| Relative Strength Index (14 RSI): | 39.1 | Sell |
| Chaikin Money Flow: | -346626 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.29 - 61.53) | Sell |
| Bollinger Bands (100): | (34.11 - 50.51) | Sell |
BIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 368.99 | Sell |
| 20-day SMA: | 350.59 | Buy |
| 50-day SMA: | 340.03 | Buy |
| 200-day SMA: | 317.13 | Buy |
| 8-day EMA: | 364.07 | Sell |
| 20-day EMA: | 355.12 | Buy |
| 50-day EMA: | 342.41 | Buy |
| 200-day EMA: | 327.95 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.39 | Sell |
| 20-day SMA: | 53.17 | Sell |
| 50-day SMA: | 46.66 | Sell |
| 200-day SMA: | 38.93 | Buy |
| 8-day EMA: | 54.03 | Sell |
| 20-day EMA: | 53.18 | Sell |
| 50-day EMA: | 48.36 | Sell |
| 200-day EMA: | 38.47 | Buy |
Bio-Rad Laboratories Earnings Growth & BIO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.76 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.49 per share, and an increase next year of $1.42 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
Bio-Rad Laboratories Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||